Empirical antimicrobial therapy after debridement | Antimicrobial therapy adaptation according to debridement samples microbiological results | Re-broadening spectrum of antimicrobial therapy after flap closure | Antimicrobial therapy adaptation according to flap samples microbiological results | |
---|---|---|---|---|
3rdGC | 5 (8.2%) | 10 (15.9%) | 10 (15.6%) | 18 (28.1%) |
Piperacillin-tazobactam | 36 (57.1%) | 22 (39.4%) | 20 (31.3%) | 10 (15.6%) |
Carbapenem | 14 (22.2%) | 8 (12.7%) | 11 (17.2%) | 9 (14.1%) |
Vancomycin | 44 (69.8%) | 26 (41.3%) | 25 (39.1%) | 23 (35.9%) |
Fluoroquinolone | 7 (11.1%) | 15 (24.2%) | 23 (35.9%) | 26 (40.6%) |